Josh Han
Papers
1
Total Citations
36
H-Index
1
About
Dr. Josh Han is a leading urologic surgeon and researcher whose work centers on advancing surgical treatments for benign prostatic hypertrophy (BPH), particularly for patients with large prostate glands. His most notable contribution is a landmark 2022 study comparing holmium laser enucleation of the prostate (HoLEP), open simple prostatectomy, and robotic simple prostatectomy—three major approaches for managing large-gland BPH. This outcomes comparison, which has garnered 36 citations, provides critical evidence guiding surgical decision-making by evaluating efficacy, safety, and recovery profiles. Dr. Han’s research directly addresses a key clinical challenge: optimizing minimally invasive techniques to reduce morbidity while maintaining durable results. His work has helped establish HoLEP and robotic approaches as viable alternatives to traditional open surgery, improving patient outcomes and shortening hospital stays. By systematically analyzing these procedures, Dr. Han has contributed to the growing body of evidence supporting tailored surgical strategies for complex BPH cases. His findings are widely cited in urology literature and have influenced practice patterns among surgeons managing this common condition. Dr. Han continues to investigate novel surgical innovations, with his research shaping the future of prostate surgery and enhancing quality of life for men with symptomatic BPH.
Research Focus
Key Achievements
Top Papers
- 1